Clinical Trial Update: A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated bevacizumab in addition to standard therapy for newly diagnosed Stage III/IV epithelial ovarian, fallopian tube, or primary periton…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Status: COMPLETED | Results posted: 2023-03-17